Tag: Cipla

cell therapy

Cipla & Stempeutics collaborate for launch of Stempeucel

0
Cipla announced that its partner Stempeutics Research has received regulatory approval by the Drug Controller General of India (DCGI) for the launch of Stempeucel...
Ciplenza

Cipla receives DCGI approval for launch of Ciplenza in India

0
Cipla announced that it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the...
Sovereign Pharma

Sovereign Pharma dispatches first batch of Remdesivir injections to Cipla

0
The Daman-based Sovereign Pharma is manufacturing the antiviral drug for Indian pharmaceutical giant Cipla, as it continues to be one of the few effective...
Cipremi

Cipla launches remdesivir under brand name CIPREMI

0
Cipla announced the launch of remdesivir under its brand name CIPREMI. The USFDA issued an Emergency Use Authorization (EUA) to Gilead Sciences for emergency...

This function has been disabled for HealthTekPak.

error: Content is protected !!